Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
"She is the one who knows": A qualitative exploration of oral and injectable PrEP as part of a community empowerment approach to HIV prevention among female sex workers in the Dominican Republic and Tanzania.
Mantsios A, Muraleetharan O, Donastorg Y, Perez M, Gomez H, Shembilu C, Beckham SW, Karver TS, Davis W, Likindikoki S, Mbwambo J, Barrington C, Kerrigan D. Mantsios A, et al. Among authors: donastorg y. PLOS Glob Public Health. 2022;2(9):e0000981. doi: 10.1371/journal.pgph.0000981. Epub 2022 Sep 15. PLOS Glob Public Health. 2022. PMID: 36712835 Free PMC article.
Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study).
Duerr A, Huang Y, Buchbinder S, Coombs RW, Sanchez J, del Rio C, Casapia M, Santiago S, Gilbert P, Corey L, Robertson MN; Step/HVTN 504 Study Team. Duerr A, et al. J Infect Dis. 2012 Jul 15;206(2):258-66. doi: 10.1093/infdis/jis342. Epub 2012 May 4. J Infect Dis. 2012. PMID: 22561365 Free PMC article. Clinical Trial.
Risk behavior among women enrolled in a randomized controlled efficacy trial of an adenoviral vector vaccine to prevent HIV acquisition.
Novak RM, Metch B, Buchbinder S, Cabello R, Donastorg Y, Figoroa JP, Abdul-Jauwad H, Joseph P, Koenig E, Metzger D, Sobieszycz M, Tyndall M, Zorilla C. Novak RM, et al. Among authors: donastorg y. AIDS. 2013 Jul 17;27(11):1763-70. doi: 10.1097/QAD.0b013e328360c83e. AIDS. 2013. PMID: 23807272 Free PMC article. Clinical Trial.
Recruitment of Caribbean female commercial sex workers at high risk of HIV infection.
Deschamps MM, Zorrilla CD, Morgan CA, Donastorg Y, Metch B, Madenwald T, Joseph P, Severe K, Garced S, Perez M, Escamilia G, Swann E, Pape JW; HVTN 907 Protocol Team. Deschamps MM, et al. Among authors: donastorg y. Rev Panam Salud Publica. 2013 Aug;34(2):92-8. Rev Panam Salud Publica. 2013. PMID: 24096973 Free PMC article.
Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles.
Goepfert PA, Elizaga ML, Seaton K, Tomaras GD, Montefiori DC, Sato A, Hural J, DeRosa SC, Kalams SA, McElrath MJ, Keefer MC, Baden LR, Lama JR, Sanchez J, Mulligan MJ, Buchbinder SP, Hammer SM, Koblin BA, Pensiero M, Butler C, Moss B, Robinson HL; HVTN 205 Study Group; National Institutes of Allergy and Infectious Diseases HIV Vaccines Trials Network. Goepfert PA, et al. J Infect Dis. 2014 Jul 1;210(1):99-110. doi: 10.1093/infdis/jiu003. Epub 2014 Jan 7. J Infect Dis. 2014. PMID: 24403557 Free PMC article. Clinical Trial.
Feasibility of Identifying a Female Sex Worker Cohort at High Risk of HIV Infection in the Caribbean for HIV Vaccine Efficacy Trials: Longitudinal Results of HVTN 907.
Deschamps MM, Metch B, Morgan CA, Zorilla CD, Donastorg Y, Swann E, Taina D, Patrice J, Pape WJ; HVTN 907 Study Team. Deschamps MM, et al. Among authors: donastorg y. J Acquir Immune Defic Syndr. 2016 Jan 1;71(1):70-7. doi: 10.1097/QAI.0000000000000796. J Acquir Immune Defic Syndr. 2016. PMID: 26761272 Free PMC article.
73 results